CDC Announces Monkeypox Vaccine Equity Pilot Program

Last week, the CDC announced their Monkeypox Vaccine Equity Pilot Program. This new pilot program is intended to reach populations that may face barriers to monkeypox vaccination, which may include differences in language, location of vaccination sites, vaccine hesitancy, mistrust of government, lack of access to on-line scheduling technology, accessibility/disability issues, immigration status, and stigma. 10,000 vials of vaccine (enough for up to 50,000 intradermal doses) have been set aside for this national pilot program. Successful proposals will demonstrate new, innovative, non-traditional ways to reach populations who are most affected by monkeypox as defined by the applicant and supported by local context and data. Find out more about the pilot program here.